DOJ drops Viatris unit Mylan from industry-wide antitrust probe

Viatris (VTRS.O) unit Mylan is no longer a subject of the U.S. Department of Justice's antitrust investigation into alleged price fixing in the generic drug industry, the parent company said on Tuesday.